PuSH - Publikationsserver des Helmholtz Zentrums München

Guarino, C.* ; Hamon, Y. ; Croix, C.* ; Lamort, A.-S. ; Dallet-Choisy, S.* ; Marchand-Adam, S.* ; Lesner, A.* ; Baranek, T.* ; Viaud-Massuard, M.C.* ; Lauritzen, C.* ; Pedersen, J.H.* ; Heuze-Vourc'h, N.* ; Si-Tahar, M.* ; Firatli, E.* ; Jenne, D. ; Gauthier, F.* ; Horwitz, M.S.* ; Borregaard, N.* ; Korkmaz, B.*

Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.

Biochem. Pharmacol. 131, 52-67 (2017)
Postprint DOI Verlagsversion bestellen
Open Access Green
Cathepsin C (CatC) is a tetrameric cysteine dipeptidyl aminopeptidase that plays a key role in activation of pro-inflammatory serine protease zymogens by removal of a N-terminal pro-dipeptide sequence. Loss of function mutations in the CatC gene is associated with lack of immune cell serine protease activities and cause Papillon-Lefevre syndrome (PLS). Also, only very low levels of elastase-like protease zymogens are detected by proteome analysis of neutrophils from PLS patients. Thus, CatC inhibitors represent new alternatives for the treatment of neutrophil protease-driven inflammatory or autoimmune diseases. We aimed to experimentally inactivate and lower neutrophil elastase-like proteases by pharmacological blocking of CatC-dependent maturation in cell-based assays and in vivo. Isolated, immature bone marrow cells from healthy donors pulse-chased in the presence of a new cell permeable cyclopropyl nitrile CatC inhibitor almost totally lack elastase. We confirmed the elimination of neutrophil elastase-like proteases by prolonged inhibition of CatC in a non-human primate. We also showed that neutrophils lacking elastase-like protease activities were still recruited to inflammatory sites. These preclinical results demonstrate that the disappearance of neutrophil elastase-like proteases as observed in PLS patients can be achieved by pharmacological inhibition of bone marrow CatC. Such a transitory inhibition of CatC might thus help to rebalance the protease load during chronic inflammatory diseases, which opens new perspectives for therapeutic applications in humans.
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cathepsin C ; Neutrophil ; Serine Protease ; Cysteine Protease ; Inhibitor ; Papillon-lefevre Syndrome; Dipeptidyl-peptidase-i; Papillon-lefevre-syndrome; Human-diseases; Proteinase-3; Elastase; Substrate; Requires; Granules; Gene; Vivo
ISSN (print) / ISBN 0006-2952
e-ISSN 0006-2952
Quellenangaben Band: 131, Heft: , Seiten: 52-67 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Oxford
Begutachtungsstatus Peer reviewed